General Information of This Metabolic Reaction (MR) (ID: MR004943)
Formula
SVG example
Hydrolyzationn
Reactant Thalidomide Product 4-hydroxythalidomide
Reactant Info Product Info
Metabolic Type Oxidation - Hydrolyzationn
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR004921 Thalidomide 2-phthalimidoglutaramic acid Conjugation - Amide Hydrolyation Thalidomide [1], [2]
MR004914 Thalidomide 4-phthalimidoglutaramic acid Conjugation - Amide Hydrolyation Thalidomide [1], [2]
MR004934 Thalidomide 5-Hydroxythalidomide Oxidation - Aromatic hydroxylation Thalidomide [3], [2]
MR004925 Thalidomide Alpha-(o-carboxybenzamido)glutarimide Conjugation - Amide Hydrolyation Thalidomide [1], [2]
MR004937 Thalidomide Cis, trans-5'-Hydroxythalidomide Oxidation - Hydrolyzationn Thalidomide [3], [2]
MR004942 Thalidomide N-Hydroxythalidomide Oxidation - Hydrolyzation Thalidomide [4]
MR004939 Thalidomide Thalidomide arene oxide Oxidation - Epoxidation Thalidomide [3], [2]
MR004941 Thalidomide Thalidomide-5-O-glucuronide Oxidation - Hydrolyzationn Thalidomide [2]
References
1 Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites
2 Thalidomide metabolism and hydrolysis: mechanisms and implications
3 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
4 Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen's disease patients. J Biochem Mol Toxicol. 2000;14(3):140-7.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.